C5a receptor antagonists (Jerini Ophthalmic)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameC5a receptor antagonists (Jerini Ophthalmic)
Drug Alias NameC5a receptor inhibitors (Jerini Ophthalmic)JPE-1375JSM-7717JSM-1375
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsInflammationReperfusion InjuryEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire Orphan Therapies Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJerini Ophthalmic IncShire Orphan Therapies Gmbh
Active IndicationsN/A
Inactive IndicationsInflammationReperfusion InjuryEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A